“…Changes in the levels of some of these chemokines, such as CXCL-6 (GCP-2), CCL-5 (RANTES) and CCL-11 (eotaxin), have been associated with CT [18,19]. As suggested previously [7], the increased membranebound DPPIV activity in CT could be related to these changes. However, the role of soluble peptidases, such as sDPPIV, in the regulation of bioactive peptides associated with several disorders is less clear than that of cell surface peptidases.…”